Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 810-388-0 | CAS number: 12067-23-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-04-07 to 2010-04-22
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline compliant study on a structural analogous read-across substance (Please refer to the Read-Across Justification in Section 13)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- , adopted February 24, 1987
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Tin sulphide
- EC Number:
- 215-248-7
- EC Name:
- Tin sulphide
- Cas Number:
- 1314-95-0
- Molecular formula:
- SSn
- IUPAC Name:
- Tin(II) sulfide
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals were received from Covance Research Products, Inc., Denver, PA on 03/31/10. Following an acclimation period of at least one week, five healthy male and five healthy, non-pregnant and nulliparous female New Zealand White rabbits were randomly assigned to the treatment group using standard methods of randomization.
The animals were born on 12/12/09. The pretest body weight range was 2.4-2.8 kg for males and 2.4 - 2.6 kg for females. The weight variation of the animals used did not exceed.:_ 20% of the mean weight.
The animals were identified by cage notation and a uniquely numbered metal eartag and housed 1/cage in suspended wire cages. Paper bedding was placed beneath the cages and changed at least three times/week. Fresh PMI Rabbit Chow (Diet #5321) was provided daily. Water was available ad libitum.
The animal room, reserved exclusively for rabbits on acute tests, was temperature controlled, had a 12- hour light/dark cycle, and was kept clean and vermin free.
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- water
- Details on dermal exposure:
- The day prior to application of the test article, the dorsal area of the trunk of each animal was clipped free of hair. The prepared site was approximately 1 0% of the body surface and remained intact.A single dose of the test article was moistened with 1.4 ml of destilled water to form a paste and applied to the prepared site under a four layered surgical gauze patch measuring 10x15 cm at a dose level of 200 mg/kg bw. The dose was based on the dry weight of the test article. Gentle pressure was applied to the gauze to aid in the distribution of the test substance over the prepared site. The torso was wrapped with plastic in a semi-occlusive manner and was secured with non-irritating tape. The test article remained in contact with the skin for 24 hours at which time the wrappings were removed. Residual test article was removed by gently washing with distilled water.
- Duration of exposure:
- 24 h
- Doses:
- 2000 mg/ kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- In vivo - The test sites were scored for dermal irritation at 24 hours postdose and on days 7 and 14 using the numerical Draize scoring code below. The skin was also evaluated for ulceration and necrosis or any evidence of tissue destruction. Additional signs were described.
Erythema & Eschar
0: No erythema
1: Very slight erythema (barely perceptible)
2: Well defined erythema
3: Moderate to severe erythema
4: Severe erythema (beet redness) to slight eschar formation (injuries in depth)
Edema
0: No edema
1: Very slight edema (barely perceptible)
2: Slight edema (edges of area well-defined by definite raising)
3: Moderate edema (raised approximately 1.0 mm)
4: Severe edema (raised more than 1.0 mm, extending beyond the area of exposure)
The animals were observed 1, 2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects. The animals were observed twice daily for 14 days for mortality.
Body weights were recorded pretest, weekly and at termination.
All animals were humanely sacrificed using C02 following study termination and examined for gross pathology. - Statistics:
- not applicable
Results and discussion
- Preliminary study:
- All animals survived the 2000 mg/kg dermal application.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality: All animals survived the 2000 mg/kg dermal application. Skin reactions were normal in all animals at all observations periods. Test article staining was noted on all dose sites at all observation periods. Body weight changes were normal. There were no abnormal physical and clinical signs noted during the observation period. Necropsy results were without any findings.
- Clinical signs:
- other: All animals survived the 2000 mg/kg dermal application. Skin reactions were normal in all animals at all observations periods. Test article staining was noted on all dose sites at all observation periods. Body weight changes were normal. There were no abn
- Gross pathology:
- All animals survived the 2000 mg/kg dermal application. Skin reactions were normal in all animals at all observations periods. Test article staining was noted on all dose sites at all observation periods. Body weight changes were normal. There were no abnormal physical and clinical signs noted during the observation period. Necropsy results were without any findings.
- Other findings:
- No other findings
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- In an acute toxicity study according to OECD guideline 402 the dermal LD50 of tin sulfide was higher than 2000 mg/kg bw.
- Executive summary:
The study according to OECD guideline 402 was used to determine the potential for toxicity of tin sulfide when applied dermally. All animals survived the 2000 mg/kg dermal application. Skin reactions were normal in all animals at all observations periods. Test item staining was noted on all dose sites at all observation periods. Body weight changes were normal. There were no abnormal physical and clinical signs noted during the observation period. Necropsy results were without any findings.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.